News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rothman Paul
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Rothman Paul (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 642 restricted stock units
@ $0 |
|
| 06/07/2023 |
3
| Rothman Paul (Director) has filed a Form 3 on LABORATORY CORP OF AMERICA HOLDINGS |
| 05/31/2023 |
4
| Rothman Paul (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
4
| Rothman Paul (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 2,478 options to buy
@ $80.72, valued at
$200k
|
|
| 06/04/2019 |
4
| Rothman Paul (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 2,336 options to buy
@ $79.21, valued at
$185k
|
|
| 05/29/2018 |
4
| Rothman Paul (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 3,131 options to buy
@ $59.09, valued at
$185k
|
|
| 05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/31/2016 |
4
| Rothman Paul (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 3,010 options to buy
@ $56.48, valued at
$170k
|
|
|
|